1-15 of 930
Interpreting Oral SERD Trial Data to Guide Metastatic Breast Cancer Care
Project Oncology®Interpreting Oral SERD Trial Data to Guide Metastatic Breast Cancer Care
Alexandria May, PharmD, BCPS
Neil M. Iyengar, MD
First-Line ADCs in Metastatic Triple-Negative Breast Cancer
On the Frontlines of Metastatic Breast CancerFirst-Line ADCs in Metastatic Triple-Negative Breast Cancer
Alexandria May, PharmD, BCPS
Heather McArthur, MD, MPH, FASCO
Zidesamtinib for ROS1-Positive Non-Small Cell Lung Cancer
On the Frontlines of Non-Small Cell Lung CancerZidesamtinib for ROS1-Positive Non-Small Cell Lung Cancer
Ryan Quigley
Alexander Drilon, MD
From Evidence to Practice: Advances in Malignant Pleural Effusion Management
Clinician's RoundtableFrom Evidence to Practice: Advances in Malignant Pleural Effusion Management
Nicholas Pastis, MD
Sequencing Decisions in R/R LBCL: CAR T-Cell Therapy and Bispecific Antibodies
Project Oncology®Sequencing Decisions in R/R LBCL: CAR T-Cell Therapy and Bispecific Antibodies
Steve Jackson, PharmD
Paolo F. Caimi, MD
Narendranath Epperla, MD, MS
Personalized CRC Screening: Applying Real-World Evidence to Test Selection
Clinician's RoundtablePersonalized CRC Screening: Applying Real-World Evidence to Test Selection
Brian P. McDonough, MD, FAAFP
David A. Johnson, MD, FACG, FACP
- advertisement
Molecular Testing in Advanced Non-Small Cell Lung Cancer
On the Frontlines of Non-Small Cell Lung CancerMolecular Testing in Advanced Non-Small Cell Lung Cancer
Alexandria May, PharmD, BCPS
Timothy F. Burns, MD, PhD
Exploring Sub-Ablative Radiation to Modulate Immunity in Mesothelioma
Project Oncology®Exploring Sub-Ablative Radiation to Modulate Immunity in Mesothelioma
John Cho, MD, PhD, FRCPC
From Durability to Discovery: Advances in ALK+ mNSCLC Treatment
Project Oncology®From Durability to Discovery: Advances in ALK+ mNSCLC Treatment
Angel Qin, MD
How Novel Strategies Could Push ALK+ mNSCLC Care Forward
Project Oncology®How Novel Strategies Could Push ALK+ mNSCLC Care Forward
Angel Qin, MD
How ALK Vaccines Could Prolong TKI Response in mNSCLC
Project Oncology®How ALK Vaccines Could Prolong TKI Response in mNSCLC
Angel Qin, MD
Patterns of Progression and Resistance in ALK+ mNSCLC
Project Oncology®Patterns of Progression and Resistance in ALK+ mNSCLC
Alice T. Shaw, MD, PhD
- advertisement
Guiding mNSCLC Treatment After ALK-TKI Progression
Project Oncology®Guiding mNSCLC Treatment After ALK-TKI Progression
Alice T. Shaw, MD, PhD
Investigating Unanswered Questions in ALK+ mNSCLC Care
Project Oncology®Investigating Unanswered Questions in ALK+ mNSCLC Care
Alice T. Shaw, MD, PhD
Advancing Metastatic Breast Cancer Research Through Philanthropy
On the Frontlines of Metastatic Breast CancerAdvancing Metastatic Breast Cancer Research Through Philanthropy
Steve Jackson, PharmD
Ted Giovanis, FHFMA, MBA